Yale Researchers Take Stem Cells One Step Closer to Replacing Parathyroid Gland Function
Yale investigators have developed a multistep process that models the biological instructions to create parathyroid gland cells from pluripotent stem cells, a significant milestone along the path toward helping people who lack the hormones released by parathyroid glands.
Knowing the Risks: The Genetics of Breast and Ovarian Cancer
Dr. Ryan Jensen’s work, spurred by a pair of WHRY grants, continues progress toward models uncovering how genetic mutations lead to cancer and helping guide patients and doctors toward decisions that can produce the best health outcomes.
Twenty years and counting for Women's Health Research at Yale
Women’s Health Research at Yale (WHRY), a self-supporting center within Yale School of Medicine, will celebrate its 20th anniversary in February. With data developed through $5 million in WHRY grants to date, Yale scientists have gone on to secure $95 million in external grants to further their research into women’s health.Source: Medicine@Yale
In Female Veterans With Early ASCVD, Secondary Prevention Falls Short
Female veterans with premature atherosclerotic cardiovascular disease (ASCVD), as well as those with extremely premature disease onset, are much less likely to receive evidence-based medical therapy, including high-intensity statins, when compared with male veterans, a new Veterans Affairs (VA) study shows.Source: TCTMD
WHRY and Elevate Expand Help for Women and Families in Need
Recognizing the urgent need to ensure the health of women in our communities, Women’s Health Research at Yale and Elevate, the university’s health policy lab, are collaborating to deploy interventions grounded in the latest and most reliable research directly to women and families.
Research Begun by WHRY Continues to Show Possible Pathway to Derail Dementia
Research is revealing the mechanisms that underlie the role of estradiol in memory so that next generation treatments for Alzheimer's disease and other dementias can specifically target these mechanisms and avoid the potential for negative side effects of systemic estrogen therapy.